{"url_path":"/sec/clpt/8-k/2026-05-13/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1285550/0001193125-26-221596-index.html","accession_number":"0001193125-26-221596","cik":"0001285550","ticker":"CLPT","issuer_name":"ClearPoint Neuro, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1285550/0001193125-26-221596-index.html","primary_entity_key":"0001285550","primary_entity_name":"ClearPoint Neuro, Inc."},"word_count":90,"has_tables":true,"body_markdown":"## Item 9.01 Financial Statements and Exhibits.\n\n(d) Exhibits.\n\nThe following exhibit is furnished herewith:\n\n \n\nExhibit 99.1\n\n[Press Release dated May 13, 2026](clpt-ex99_1.htm)\n\nExhibit 99.2\n\n[Investor Presentation dated May 13, 2026](clpt-ex99_2.htm)\n\nExhibit 104\n\nCover Page Interactive Data File (embedded within the Inline XBRL document)\n\n \n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\n \n\nCLEARPOINT NEURO, INC.\n\n \n\n \n\n \n\n \n\nDate:\n\nMay 13, 2026\n\nBy:\n\n/s/ Danilo D'Alessandro\n\n \n\n \n\n \n\nDanilo D'Alessandro\nChief Financial Officer"}